Severe Combined Immunodeficiency (SCID) Screening in Arizona: Lessons Learned from the First 2 Years.

Natalie A BoothCatherine M FreemanBenjamin L WrightChristine RukasinPriscila BadiaMichael DainesCindy S BauerHolly Miller

Published in: Journal of clinical immunology (2022)

Over 2 years, NBS in Arizona confirmed an incidence more than 2.5 times that reported nationally. This increased incidence is likely reflective of Arizona's unique population profile, with a higher percentage of Native American population. The findings in our non-SCID cohort are in alignment with previously published data, except for an increased percentage of infants of Hispanic/Latino ethnicity, possibly reflecting Arizona's increased percentage of Hispanic/Latino population compared to the general US population.

Keyphrases

african american
randomized controlled trial
electronic health record
early onset
big data
deep learning
artificial intelligence